Acasti Pharma Inc (ACST) Stock Up Big After Receiving Positive Feedback on CaPre from FDA
The stock is currently trading higher by 66.25% or $1.06 following the positive news, hitting $2.66 per share at the time of us publishing this…
The stock is currently trading higher by 66.25% or $1.06 following the positive news, hitting $2.66 per share at the time of us publishing this…
